BamSEC and AlphaSense Join Forces
Learn More

CorMedix Inc.

NASDAQ: CRMD    
Share price (1/6/25): $7.93    
Market cap (1/6/25): $481 million

Material Contracts Filter

EX-10.17
from 10-K 7 pages Separation Agreement and Release
12/34/56
EX-10.1
from 10-Q 12 pages CorMedix Inc. Indemnification Agreement
12/34/56
EX-10.1
from 10-K 27 pages License and Assignment Agreement Between Nd Partners LLC and Cormedix, Inc. License and Assignment Agreement
12/34/56
EX-10.1
from 8-K 42 pages CorMedix Inc. Executive Employment Agreement
12/34/56
EX-10.2
from 8-K 2 pages Personal and Confidential [Date]
12/34/56
EX-10.1
from 8-K 3 pages CorMedix Inc. Executive Bonus Plan
12/34/56
EX-10.2
from 10-Q 4 pages Separation Agreement and Release
12/34/56
EX-10.1
from 10-Q 6 pages Separation Agreement and Release
12/34/56
EX-10.1
from 8-K 3 pages October 26, 2021 Matthew David, M.D. Re: Interim Chief Executive Officer Letter Agreement 1. Base Salary. Section 4(a) of the Employment Agreement Is Amended to Read as Follows
12/34/56
EX-10.1
from 10-Q 23 pages Executive Employment Agreement
12/34/56
EX-10.10
from 10-K 24 pages Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 22 pages Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 18 pages Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 18 pages CorMedix Inc. 2019 Omnibus Stock Incentive Plan Approved by the Board October 16, 2019 and by the Stockholders on November 26, 2019
12/34/56
EX-10.1
from 8-K 23 pages Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 4 pages September 25, 2019 Re: Waiver and Consent With Respect to Warrants Dear Sirs
12/34/56
EX-10.1
from 8-K 6 pages Warrant Amendment Agreement
12/34/56
EX-10.1
from 8-K 14 pages Amended and Restated Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 46 pages Securities Exchange Agreement by and Among CorMedix Inc. and the Existing Securityholders Listed on the Schedule of Holders August 14, 2019
12/34/56
EX-10.1
from 10-Q 20 pages Executive Employment Agreement
12/34/56